Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Migraine

  Free Subscription


Articles published in Cephalalgia

Retrieve available abstracts of 334 articles:
HTML format



Single Articles


    July 2020
  1. DIENER HC, Tassorelli C, Dodick DW, Silberstein SD, et al
    Guidelines for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults.
    Cephalalgia. 2020 Jul 28:333102420941839. doi: 10.1177/0333102420941839.
    PubMed     Abstract available


  2. DE ICCO R, Fiamingo G, Greco R, Bottiroli S, et al
    Neurophysiological and biomolecular effects of erenumab in chronic migraine: An open label study.
    Cephalalgia. 2020 Jul 26:333102420942230. doi: 10.1177/0333102420942230.
    PubMed     Abstract available


  3. SAFFI H, Do TP, Hansen JM, Dodick DW, et al
    The migraine landscape on YouTube: A review of YouTube as a source of information on migraine.
    Cephalalgia. 2020 Jul 23:333102420943891. doi: 10.1177/0333102420943891.
    PubMed     Abstract available


  4. BOJAZAR R, Do TP, Hansen JM, Dodick DW, et al
    Googling migraine: A study of Google as an information resource of migraine management.
    Cephalalgia. 2020 Jul 23:333102420942241. doi: 10.1177/0333102420942241.
    PubMed     Abstract available


  5. DE BOER I, MaassenVanDenBrink A, Terwindt GM
    The potential danger of blocking CGRP for treating migraine in CADASIL patients.
    Cephalalgia. 2020 Jul 13:333102420941814. doi: 10.1177/0333102420941814.
    PubMed     Abstract available


  6. TFELT-HANSEN P, Diener HC
    Pain freedom after 2 hours should be the primary outcome in controlled trials treating migraine attacks.
    Cephalalgia. 2020 Jul 13:333102420941827. doi: 10.1177/0333102420941827.
    PubMed     Abstract available


  7. PAN YJ, Chen YC, Lu SR, Juang KD, et al
    The influence of friendship on migraine in young adolescents: A social network analysis.
    Cephalalgia. 2020 Jul 7:333102420940700. doi: 10.1177/0333102420940700.
    PubMed     Abstract available


    June 2020
  8. RUSTICHELLI C, Bellei E, Bergamini S, Monari E, et al
    Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study.
    Cephalalgia. 2020 Jun 26:333102420937742. doi: 10.1177/0333102420937742.
    PubMed     Abstract available


  9. LAMBRU G, Elias LA, Yakkaphan P, Renton T, et al
    Migraine presenting as isolated facial pain: A prospective clinical analysis of 58 cases.
    Cephalalgia. 2020 Jun 17:333102420933277. doi: 10.1177/0333102420933277.
    PubMed     Abstract available


  10. GRAZZI L, Usai S, Bolognini N, Grignani E, et al
    No efficacy of transcranial direct current stimulation on chronic migraine with medication overuse: A double blind, randomised clinical trial.
    Cephalalgia. 2020 Jun 14:333102420931050. doi: 10.1177/0333102420931050.
    PubMed     Abstract available


  11. LAI KL, Niddam DM, Fuh JL, Chen WT, et al
    Reply to letter to the editor: Insights into chronic migraine pathophysiology - what measures of gray matter reveal.
    Cephalalgia. 2020 Jun 14:333102420933262. doi: 10.1177/0333102420933262.
    PubMed    


  12. WURTHMANN S, Nagel S, Hadaschik E, Schlott S, et al
    Impaired wound healing in a migraine patient as a possible side effect of calcitonin gene-related peptide receptor antibody treatment: A case report.
    Cephalalgia. 2020 Jun 14:333102420933571. doi: 10.1177/0333102420933571.
    PubMed     Abstract available


  13. DESOUZA DD, Cowan RP
    Insights into chronic migraine pathophysiology - what measures of gray matter reveal.
    Cephalalgia. 2020 Jun 14:333102420933263. doi: 10.1177/0333102420933263.
    PubMed    


  14. BARBANTI P, Aurilia C, Egeo G, Fofi L, et al
    Dopaminergic symptoms in migraine: A cross-sectional study on 1148 consecutive headache center-based patients.
    Cephalalgia. 2020 Jun 2:333102420929023. doi: 10.1177/0333102420929023.
    PubMed     Abstract available


  15. TANG C, Unekawa M, Shibata M, Tomita Y, et al
    Characteristics of cortical spreading depression and c-Fos expression in transgenic mice having a mutation associated with familial hemiplegic migraine 2.
    Cephalalgia. 2020 Jun 2:333102420929028. doi: 10.1177/0333102420929028.
    PubMed     Abstract available


  16. NIDDAM DM, Wang SJ
    Reply to Letter to the Editor, "Creatine loading for chronic migraine?"
    Cephalalgia. 2020 Jun 2:333102420931051. doi: 10.1177/0333102420931051.
    PubMed    


  17. OSTOJIC SM
    Creatine loading for chronic migraine?
    Cephalalgia. 2020 Jun 2:333102420931055. doi: 10.1177/0333102420931055.
    PubMed    


    May 2020
  18. VIANA M, Hougaard A, Phu Do T
    The depiction of migraine visual aura on the internet.
    Cephalalgia. 2020 May 27:333102420927027. doi: 10.1177/0333102420927027.
    PubMed     Abstract available


  19. CHRISTENSEN SL, Munro G, Petersen S, Shabir A, et al
    ATP sensitive potassium (KATP) channel inhibition: A promising new drug target for migraine.
    Cephalalgia. 2020 May 16:333102420925513. doi: 10.1177/0333102420925513.
    PubMed     Abstract available


  20. PAN LH, Wang YF, Lai KL, Chen WT, et al
    Mechanical punctate pain threshold is associated with headache frequency and phase in patients with migraine.
    Cephalalgia. 2020 May 16:333102420925540. doi: 10.1177/0333102420925540.
    PubMed     Abstract available


    April 2020
  21. ILJAZI A, Ashina H, Lipton RB, Chaudhry B, et al
    Dizziness and vertigo during the prodromal phase and headache phase of migraine: A systematic review and meta-analysis.
    Cephalalgia. 2020 Apr 29:333102420921855. doi: 10.1177/0333102420921855.
    PubMed     Abstract available


  22. MARTINEZ JM, Hindiyeh N, Anglin G, Kalidas K, et al
    Assessment of immunogenicity from galcanezumab phase 3 trials in patients with episodic or chronic migraine.
    Cephalalgia. 2020 Apr 27:333102420920642. doi: 10.1177/0333102420920642.
    PubMed    


  23. REIDY BL, Riddle EJ, Powers SW, Slater SK, et al
    Clinic-based characterization of continuous headache in children and adolescents: Comparing youth with chronic migraine to those with new daily persistent headache.
    Cephalalgia. 2020 Apr 26:333102420920644. doi: 10.1177/0333102420920644.
    PubMed    


  24. GUO S, Falkenberg K, Schytz HW, Caparso A, et al
    Low frequency activation of the sphenopalatine ganglion does not induce migraine-like attacks in migraine patients.
    Cephalalgia. 2020 Apr 22:333102420921156. doi: 10.1177/0333102420921156.
    PubMed    


  25. LAI KL, Niddam DM, Fuh JL, Chen WT, et al
    Cortical morphological changes in chronic migraine in a Taiwanese cohort: Surface- and voxel-based analyses.
    Cephalalgia. 2020 Apr 16:333102420920005. doi: 10.1177/0333102420920005.
    PubMed    


  26. HVEDSTRUP J, Kolding LT, Ashina M, Schytz HW, et al
    Increased neck muscle stiffness in migraine patients with ictal neck pain: A shear wave elastography study.
    Cephalalgia. 2020 Apr 15:333102420919998. doi: 10.1177/0333102420919998.
    PubMed    


  27. AMANAT M, Ashrafi MR
    The use of anti-epileptic drugs in prevention of migraine in children and adolescents.
    Cephalalgia. 2020 Apr 10:333102420918526. doi: 10.1177/0333102420918526.
    PubMed    


  28. GAKI E, Siapkara A, Morgan S, Branch S, et al
    Sodium valproate in paediatric migraine.
    Cephalalgia. 2020 Apr 10:333102420918527. doi: 10.1177/0333102420918527.
    PubMed    


  29. DAGHLAS I, Rist PM, Chasman DI
    Effect of genetic liability to migraine on cognition and brain volume: A Mendelian randomization study.
    Cephalalgia. 2020 Apr 4:333102420916751. doi: 10.1177/0333102420916751.
    PubMed    


    March 2020
  30. MARCUS SC, Shewale AR, Silberstein SD, Lipton RB, et al
    Comparison of healthcare resource utilization and costs among patients with migraine with potentially adequate and insufficient triptan response.
    Cephalalgia. 2020 Mar 29:333102420915167. doi: 10.1177/0333102420915167.
    PubMed    


  31. CHRISTENSEN SL, Ernstsen C, Olesen J, Kristensen DM, et al
    No central action of CGRP antagonising drugs in the GTN mouse model of migraine.
    Cephalalgia. 2020 Mar 29:333102420914913. doi: 10.1177/0333102420914913.
    PubMed    


  32. FALKENBERG K, Bjerg HR, Olesen J
    Subcutaneous sumatriptan reduces cilostazol induced headache in migraine patients.
    Cephalalgia. 2020 Mar 26:333102420915166. doi: 10.1177/0333102420915166.
    PubMed    


  33. TEPPER SJ, Ashina M, Reuter U, Brandes JL, et al
    Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study.
    Cephalalgia. 2020 Mar 26:333102420912726. doi: 10.1177/0333102420912726.
    PubMed    


  34. PERENBOOM MJ, van de Ruit M, Zielman R, van den Maagdenberg AM, et al
    Enhanced pre-ictal cortical responsivity in migraine patients assessed by visual chirp stimulation.
    Cephalalgia. 2020 Mar 18:333102420912725. doi: 10.1177/0333102420912725.
    PubMed    


  35. KARSAN N, Bose PR, Thompson C, Newman J, et al
    Headache and non-headache symptoms provoked by nitroglycerin in migraineurs: A human pharmacological triggering study.
    Cephalalgia. 2020 Mar 12:333102420910114. doi: 10.1177/0333102420910114.
    PubMed     Abstract available


  36. MEYLAKH N, Marciszewski KK, Di Pietro F, Macefield VG, et al
    Altered regional cerebral blood flow and hypothalamic connectivity immediately prior to a migraine headache.
    Cephalalgia. 2020 Mar 12:333102420911623. doi: 10.1177/0333102420911623.
    PubMed     Abstract available


  37. ILJAZI A, Chua A, Rich-Fiondella R, Veronesi M, et al
    Unrecognized challenges of treating status migrainosus: An observational study.
    Cephalalgia. 2020 Mar 12:333102420911461. doi: 10.1177/0333102420911461.
    PubMed     Abstract available


  38. LIPTON RB, Marcus SC, Shewale AR, Dodick DW, et al
    Acute treatment patterns in patients with migraine newly initiating a triptan.
    Cephalalgia. 2020 Mar 5:333102420905307. doi: 10.1177/0333102420905307.
    PubMed     Abstract available


  39. CHALMER MA, Olesen J
    Letter to the editor regarding proposed new diagnostic criteria for migraine.
    Cephalalgia. 2020 Mar 3:333102420911190. doi: 10.1177/0333102420911190.
    PubMed    


    February 2020
  40. NIDDAM DM, Lai KL, Tsai SY, Lin YR, et al
    Brain metabolites in chronic migraine patients with medication overuse headache.
    Cephalalgia. 2020 Feb 25:333102420908579. doi: 10.1177/0333102420908579.
    PubMed     Abstract available


  41. ASHINA M, Saper J, Cady R, Schaeffler BA, et al
    Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1).
    Cephalalgia. 2020 Feb 19:333102420905132. doi: 10.1177/0333102420905132.
    PubMed     Abstract available


  42. HANSEN LC, Gaul C, Pogatzki-Zahn E, Baron R, et al
    Do doctors treat themselves differently than their patients? Study on the self-treatment of migraine among German neurologists and pain specialists.
    Cephalalgia. 2020 Feb 17:333102420907593. doi: 10.1177/0333102420907593.
    PubMed     Abstract available


  43. ALPUENTE A, Tassorelli C, Diener HC, Silberstein SD, et al
    Have the IHS Guidelines for controlled trials of acute treatment of migraine attacks been followed? Laying the ground for the 4th edition.
    Cephalalgia. 2020 Feb 14:333102420906843. doi: 10.1177/0333102420906843.
    PubMed     Abstract available


  44. BORTE S, Zwart JA, Skogholt AH, Gabrielsen ME, et al
    Mitochondrial genome-wide association study of migraine - the HUNT Study.
    Cephalalgia. 2020 Feb 14:333102420906835. doi: 10.1177/0333102420906835.
    PubMed     Abstract available


    January 2020
  45. HOLLAND PR, Sureda-Gibert P, Vila-Pueyo M
    Rapid uptake of sumatriptan into the brain: An ongoing question of blood-brain barrier permeability.
    Cephalalgia. 2020 Jan 30:333102420905131. doi: 10.1177/0333102420905131.
    PubMed    


  46. HUANG C, Chen SP, Huang YH, Chen HY, et al
    HLA class I alleles are associated with clinic-based migraine and increased risks of chronic migraine and medication overuse.
    Cephalalgia. 2020 Jan 23:333102420902228. doi: 10.1177/0333102420902228.
    PubMed     Abstract available


  47. PENG KP, May A
    Redefining migraine phases - a suggestion based on clinical, physiological, and functional imaging evidence.
    Cephalalgia. 2020 Jan 13:333102419898868. doi: 10.1177/0333102419898868.
    PubMed     Abstract available


    December 2019
  48. MINEN MT, Morio K, Schaubhut KB, Powers SW, et al
    Focus group findings on the migraine patient experience during research studies and ideas for future investigations.
    Cephalalgia. 2019 Dec 23:333102419888230. doi: 10.1177/0333102419888230.
    PubMed     Abstract available


  49. ARAYA EI, Turnes JM, Barroso AR, Chichorro JG, et al
    Contribution of intraganglionic CGRP to migraine-like responses in male and female rats.
    Cephalalgia. 2019 Dec 19:333102419896539. doi: 10.1177/0333102419896539.
    PubMed     Abstract available


  50. MUZZI M, Zecchi R, Ranieri G, Urru M, et al
    Ultra-rapid brain uptake of subcutaneous sumatriptan in the rat: Implication for cluster headache treatment.
    Cephalalgia. 2019 Dec 18:333102419896370. doi: 10.1177/0333102419896370.
    PubMed     Abstract available


  51. PENG KP, Ziegeler C, Basedau H, Wang SJ, et al
    We still have no data to change the diagnostic criteria for chronic migraine.
    Cephalalgia. 2019 Dec 15:333102419895772. doi: 10.1177/0333102419895772.
    PubMed    


  52. GUGLIELMETTI M, Raggi A, Ornello R, Sacco S, et al
    The clinical and public health implications and risks of widening the definition of chronic migraine.
    Cephalalgia. 2019 Dec 15:333102419895777. doi: 10.1177/0333102419895777.
    PubMed     Abstract available


  53. BRANDES JL, Diener HC, Dolezil D, Freeman MC, et al
    The spectrum of response to erenumab in patients with chronic migraine and subgroup analysis of patients achieving >/=50%, >/=75%, and 100% response.
    Cephalalgia. 2019 Dec 9:333102419894559. doi: 10.1177/0333102419894559.
    PubMed     Abstract available


  54. WARFVINGE K, Edvinsson L
    Cellular distribution of PACAP-38 and PACAP receptors in the rat brain: Relation to migraine activated regions.
    Cephalalgia. 2019 Dec 6:333102419893962. doi: 10.1177/0333102419893962.
    PubMed     Abstract available


  55. MAITROT-MANTELET L, Hugon-Rodin J, Vatel M, Marcellin L, et al
    Migraine in relation with endometriosis phenotypes: Results from a French case-control study.
    Cephalalgia. 2019 Dec 6:333102419893965. doi: 10.1177/0333102419893965.
    PubMed     Abstract available


  56. LAPP HS, Sabatowski R, Weidner K, Croy I, et al
    C-tactile touch perception in migraineurs - a case-control study.
    Cephalalgia. 2019 Dec 1:333102419889349. doi: 10.1177/0333102419889349.
    PubMed     Abstract available


    November 2019
  57. POZO-ROSICH P, Torres-Ferrus M
    When does chronic migraine strike?
    Cephalalgia. 2019 Nov 22:333102419885375. doi: 10.1177/0333102419885375.
    PubMed    


  58. BRANDES JL, Kudrow D, Yeung PP, Sakai F, et al
    Effects of fremanezumab on the use of acute headache medication and associated symptoms of migraine in patients with episodic migraine.
    Cephalalgia. 2019 Nov 21:333102419885905. doi: 10.1177/0333102419885905.
    PubMed     Abstract available


  59. KNIEVEL K, Buchanan AS, Lombard L, Baygani S, et al
    Lasmiditan for the acute treatment of migraine: Subgroup analyses by prior response to triptans.
    Cephalalgia. 2019 Nov 19:333102419889350. doi: 10.1177/0333102419889350.
    PubMed     Abstract available


  60. MARCONI E, Pecchioli S, Nica M, Colombo D, et al
    Epidemiology and determinants of chronic migraine: A real-world cohort study, with nested case-control analysis, in primary care in Italy.
    Cephalalgia. 2019 Nov 19:333102419889351. doi: 10.1177/0333102419889351.
    PubMed     Abstract available


  61. ASHINA M, Kudrow D, Reuter U, Dolezil D, et al
    Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions.
    Cephalalgia. 2019 Nov 10:333102419888222. doi: 10.1177/0333102419888222.
    PubMed     Abstract available


  62. AMANAT M, Togha M, Agah E, Ramezani M, et al
    Cinnarizine and sodium valproate as the preventive agents of pediatric migraine: A randomized double-blind placebo-controlled trial.
    Cephalalgia. 2019 Nov 10:333102419888485. doi: 10.1177/0333102419888485.
    PubMed     Abstract available


  63. WOLF J, Danno D, Takeshima T, Vancleef LM, et al
    The relation between emotion regulation and migraine: A cross-cultural study on the moderating effect of culture.
    Cephalalgia. 2019 Nov 5:333102419885394. doi: 10.1177/0333102419885394.
    PubMed     Abstract available


  64. YOUNIS S, Christensen CE, Toft NM, Soborg T, et al
    Investigation of distinct molecular pathways in migraine induction using calcitonin gene-related peptide and sildenafil.
    Cephalalgia. 2019 Nov 4:333102419882474. doi: 10.1177/0333102419882474.
    PubMed     Abstract available


  65. PLANCHUELO-GOMEZ A, Garcia-Azorin D, Guerrero AL, Aja-Fernandez S, et al
    Structural connectivity alterations in chronic and episodic migraine: A diffusion magnetic resonance imaging connectomics study.
    Cephalalgia. 2019 Nov 1:333102419885392. doi: 10.1177/0333102419885392.
    PubMed     Abstract available


    October 2019
  66. CHIANG CC, Starling AJ, Buras MR, Golafshar MA, et al
    A pilot exploratory study comparing the King-Devick test (KDT) during and between migraine attacks.
    Cephalalgia. 2019 Oct 29:333102419885381. doi: 10.1177/0333102419885381.
    PubMed     Abstract available


  67. VGONTZAS A, Renthal W
    Migraine-associated gene expression in cell types of the central and peripheral nervous system.
    Cephalalgia. 2019 Oct 29:333102419877834. doi: 10.1177/0333102419877834.
    PubMed     Abstract available


  68. PISANU C, Lundin E, Preisig M, Gholam-Rezaee M, et al
    Major depression subtypes are differentially associated with migraine subtype, prevalence and severity.
    Cephalalgia. 2019 Oct 24:333102419884935. doi: 10.1177/0333102419884935.
    PubMed     Abstract available


  69. SHI S, Han Y, Wang D, Guo P, et al
    PD-L1 and PD-1 expressed in trigeminal ganglia may inhibit pain in an acute migraine model.
    Cephalalgia. 2019 Oct 22:333102419883374. doi: 10.1177/0333102419883374.
    PubMed     Abstract available


  70. XU J, Kong F, Buse DC
    Predictors of episodic migraine transformation to chronic migraine: A systematic review and meta-analysis of observational cohort studies.
    Cephalalgia. 2019 Oct 21:333102419883355. doi: 10.1177/0333102419883355.
    PubMed     Abstract available


  71. SCHULTE LH, Peng KP
    Current understanding of premonitory networks in migraine: A window to attack generation.
    Cephalalgia. 2019 Oct 15:333102419883375. doi: 10.1177/0333102419883375.
    PubMed     Abstract available


  72. VAN OOSTERHOUT WP, Schoonman GG, Saal DP, Thijs RD, et al
    Abnormal cardiovascular response to nitroglycerin in migraine.
    Cephalalgia. 2019 Oct 9:333102419881657. doi: 10.1177/0333102419881657.
    PubMed     Abstract available


  73. KAMM K, Straube A, Ruscheweyh R
    Calcitonin gene-related peptide levels in tear fluid are elevated in migraine patients compared to healthy controls.
    Cephalalgia. 2019;39:1535-1543.
    PubMed     Abstract available


    September 2019
  74. TFELT-HANSEN P, Diener HC, Steiner TJ
    Problematic presentation and use of efficacy measures in current trials of CGRP monoclonal antibodies for episodic migraine prevention: A mini-review.
    Cephalalgia. 2019 Sep 23:333102419877663. doi: 10.1177/0333102419877663.
    PubMed     Abstract available


  75. CHALMER MA, Hansen TF, Lebedeva ER, Dodick DW, et al
    Proposed new diagnostic criteria for chronic migraine.
    Cephalalgia. 2019 Sep 22:333102419877171. doi: 10.1177/0333102419877171.
    PubMed     Abstract available


  76. TERRIN A, Mainardi F, Lisotto C, Mampreso E, et al
    A prospective study on osmophobia in migraine versus tension-type headache in a large series of attacks.
    Cephalalgia. 2019 Sep 19:333102419877661. doi: 10.1177/0333102419877661.
    PubMed     Abstract available


  77. MARTINS IP, Westerfield M, Lopes M, Maruta C, et al
    Brain state monitoring for the future prediction of migraine attacks.
    Cephalalgia. 2019 Sep 17:333102419877660. doi: 10.1177/0333102419877660.
    PubMed     Abstract available


  78. DIENER HC, Goadsby PJ, Ashina M, Al-Karagholi MA, et al
    Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial.
    Cephalalgia. 2019 Sep 15:333102419876920. doi: 10.1177/0333102419876920.
    PubMed     Abstract available


  79. EVERS S, Brockmann N, Summ O, Husstedt IW, et al
    Primary headache and migraine in headache specialists - does personal history of doctors matter?
    Cephalalgia. 2019 Sep 3:333102419873671. doi: 10.1177/0333102419873671.
    PubMed     Abstract available


    August 2019
  80. MAY A, Burstein R
    Hypothalamic regulation of headache and migraine.
    Cephalalgia. 2019 Aug 29:333102419867280. doi: 10.1177/0333102419867280.
    PubMed     Abstract available


  81. FRIEDMAN DI, Rajan B, Seidmann A
    A randomized trial of telemedicine for migraine management.
    Cephalalgia. 2019 Aug 26:333102419868250. doi: 10.1177/0333102419868250.
    PubMed     Abstract available


  82. BRANDES JL, Klise S, Krege JH, Case M, et al
    Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study).
    Cephalalgia. 2019 Aug 21:333102419864132. doi: 10.1177/0333102419864132.
    PubMed     Abstract available


  83. MARTINS LB, Rodrigues AMDS, Monteze NM, Tibaes JRB, et al
    Double-blind placebo-controlled randomized clinical trial of ginger (Zingiber officinale Rosc.) in the prophylactic treatment of migraine.
    Cephalalgia. 2019 Aug 9:333102419869319. doi: 10.1177/0333102419869319.
    PubMed     Abstract available


  84. HUANG TC, Wang SJ, Kheradmand A
    Vestibular migraine: An update on current understanding and future directions.
    Cephalalgia. 2019 Aug 8:333102419869317. doi: 10.1177/0333102419869317.
    PubMed     Abstract available


    July 2019
  85. KUAN AS, Chen SP, Wang YF, Fuh JL, et al
    Risk factors and psychological impact of syncope in migraine patients.
    Cephalalgia. 2019 Jul 15:333102419865253. doi: 10.1177/0333102419865253.
    PubMed     Abstract available


  86. GHANIZADA H, Al-Mahdi Al-Karagholi M, Arngrim N, Olesen J, et al
    PACAP27 induces migraine-like attacks in migraine patients.
    Cephalalgia. 2019 Jul 12:333102419864507. doi: 10.1177/0333102419864507.
    PubMed     Abstract available


  87. CHRISTENSEN SL, Petersen S, Kristensen DM, Olesen J, et al
    Targeting CGRP via receptor antagonism and antibody neutralisation in two distinct rodent models of migraine-like pain.
    Cephalalgia. 2019 Jul 9:333102419861726. doi: 10.1177/0333102419861726.
    PubMed     Abstract available


  88. DOTY EG, Krege JH, Jin L, Raskin J, et al
    Sustained responses to lasmiditan: Results from post-hoc analyses of two Phase 3 randomized clinical trials for acute treatment of migraine.
    Cephalalgia. 2019 Jul 3:333102419859313. doi: 10.1177/0333102419859313.
    PubMed     Abstract available


  89. FARRIS SG, Thomas JG, Abrantes AM, Lipton RB, et al
    Anxiety sensitivity and intentional avoidance of physical activity in women with probable migraine.
    Cephalalgia. 2019 Jul 1:333102419861712. doi: 10.1177/0333102419861712.
    PubMed     Abstract available


  90. MAGNI G, Boccazzi M, Bodini A, Abbracchio MP, et al
    Basal astrocyte and microglia activation in the central nervous system of Familial Hemiplegic Migraine Type I mice.
    Cephalalgia. 2019 Jul 1:333102419861710. doi: 10.1177/0333102419861710.
    PubMed     Abstract available


    June 2019
  91. DODICK DW, Lipton RB, Silberstein S, Goadsby PJ, et al
    Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial.
    Cephalalgia. 2019 Jun 24:333102419858355. doi: 10.1177/0333102419858355.
    PubMed     Abstract available


  92. STEFANO MD, Pucci E, Miceli E, Pagani E, et al
    Prevalence and pathophysiology of post-prandial migraine in patients with functional dyspepsia.
    Cephalalgia. 2019 Jun 15:333102419857596. doi: 10.1177/0333102419857596.
    PubMed     Abstract available


  93. HOFFMAN V, Xue F, Ezzy SM, Yusuf A, et al
    Risk of cardiovascular and cerebrovascular events and mortality in patients with migraine receiving prophylactic treatments: An observational cohort study.
    Cephalalgia. 2019 Jun 13:333102419856630. doi: 10.1177/0333102419856630.
    PubMed     Abstract available


  94. KREGE JH, Rizzoli PB, Liffick E, Doty EG, et al
    Safety findings from Phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN.
    Cephalalgia. 2019 Jun 5:333102419855080. doi: 10.1177/0333102419855080.
    PubMed     Abstract available


  95. OGUZ AKARSU E, Baykan B, Ertas M, Zarifoglu M, et al
    The persistence versus interchangeability of migraine and tension-type headaches in a 5-year population-based validated survey.
    Cephalalgia. 2019 Jun 4:333102419852359. doi: 10.1177/0333102419852359.
    PubMed     Abstract available


  96. MONTAZERLOTFELAHI H, Amanat M, Tavasoli AR, Agah E, et al
    Levetiracetam for prophylactic treatment of pediatric migraine: A randomized double-blind placebo-controlled trial.
    Cephalalgia. 2019 Jun 1:333102419851814. doi: 10.1177/0333102419851814.
    PubMed     Abstract available


  97. MEYERS JL, Davis KL, Lenz RA, Sakai F, et al
    Treatment patterns and characteristics of patients with migraine in Japan: A retrospective analysis of health insurance claims data.
    Cephalalgia. 2019 Jun 1:333102419851855. doi: 10.1177/0333102419851855.
    PubMed     Abstract available


    May 2019
  98. ASHINA M, Goadsby PJ, Reuter U, Silberstein S, et al
    Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine.
    Cephalalgia. 2019 May 30:333102419854082. doi: 10.1177/0333102419854082.
    PubMed     Abstract available


  99. BRAGATTO MM, Bevilaqua-Grossi D, Benatto MT, Lodovichi SS, et al
    Is the presence of neck pain associated with more severe clinical presentation in patients with migraine? A cross-sectional study.
    Cephalalgia. 2019 May 27:333102419854061. doi: 10.1177/0333102419854061.
    PubMed     Abstract available



  100. Corrigendum: CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications.
    Cephalalgia. 2019 May 24:333102419854298. doi: 10.1177/0333102419854298.
    PubMed    


  101. DODICK DW, Silberstein SD, Lipton RB, DeGryse RE, et al
    Early onset of effect of onabotulinumtoxinA for chronic migraine treatment: Analysis of PREEMPT data.
    Cephalalgia. 2019 May 21:333102418825382. doi: 10.1177/0333102418825382.
    PubMed     Abstract available


  102. KOGELMAN LJ, Falkenberg K, Halldorsson GH, Poulsen LU, et al
    Comparing migraine with and without aura to healthy controls using RNA sequencing.
    Cephalalgia. 2019 May 19:333102419851812. doi: 10.1177/0333102419851812.
    PubMed     Abstract available


  103. RUFF DD, Ford JH, Tockhorn-Heidenreich A, Sexson M, et al
    Efficacy of galcanezumab in patients with chronic migraine and a history of preventive treatment failure.
    Cephalalgia. 2019 May 19:333102419847957. doi: 10.1177/0333102419847957.
    PubMed     Abstract available


  104. HAANES KA, Labastida-Ramirez A, Blixt FW, Rubio-Beltran E, et al
    Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models.
    Cephalalgia. 2019 May 19:333102419851810. doi: 10.1177/0333102419851810.
    PubMed     Abstract available


  105. KHAN S, Amin FM, Fliedner FP, Christensen CE, et al
    Investigating macrophage-mediated inflammation in migraine using ultrasmall superparamagnetic iron oxide-enhanced 3T magnetic resonance imaging.
    Cephalalgia. 2019 May 19:333102419848122. doi: 10.1177/0333102419848122.
    PubMed     Abstract available


  106. TANG W, Zhang M, Qiu E, Kong S, et al
    A Chinese family with familial hemiplegic migraine type 2 due to a novel missense mutation in ATP1A2.
    Cephalalgia. 2019 May 3:333102419847738. doi: 10.1177/0333102419847738.
    PubMed     Abstract available


  107. DUMKRIEGER G, Chong CD, Ross K, Berisha V, et al
    Static and dynamic functional connectivity differences between migraine and persistent post-traumatic headache: A resting-state magnetic resonance imaging study.
    Cephalalgia. 2019 May 1:333102419847728. doi: 10.1177/0333102419847728.
    PubMed     Abstract available


  108. KAISER EA, Igdalova A, Aguirre GK, Cucchiara B, et al
    A web-based, branching logic questionnaire for the automated classification of migraine.
    Cephalalgia. 2019 May 1:333102419847749. doi: 10.1177/0333102419847749.
    PubMed     Abstract available


  109. DEEN M, Martinelli D, Pijpers J, Diener HC, et al
    Adherence to the 2008 IHS guidelines for controlled trials of drugs for the preventive treatment of chronic migraine in adults.
    Cephalalgia. 2019 May 1:333102419847751. doi: 10.1177/0333102419847751.
    PubMed     Abstract available


    April 2019
  110. GOADSBY PJ, Paemeleire K, Broessner G, Brandes J, et al
    Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study.
    Cephalalgia. 2019 Apr 13:333102419835459. doi: 10.1177/0333102419835459.
    PubMed     Abstract available


  111. ALBERS L, Kries RV, Straube A, Heinen F, et al
    Age- and sex-specific first health care use for migraine in 2016 in children and adolescents from prospectively collected health insurance data in Germany.
    Cephalalgia. 2019 Apr 11:333102419844543. doi: 10.1177/0333102419844543.
    PubMed     Abstract available


  112. WEN KX, Ikram MA, Franco OH, Vernooij M, et al
    Association of migraine with calcification in major vessel beds: The Rotterdam Study.
    Cephalalgia. 2019 Apr 8:333102419843148. doi: 10.1177/0333102419843148.
    PubMed     Abstract available


  113. ABU-ARAFEH I, Hershey AD, Diener HC, Tassorelli C, et al
    Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition.
    Cephalalgia. 2019 Apr 4:333102419842188. doi: 10.1177/0333102419842188.
    PubMed     Abstract available


    March 2019
  114. TOLNER EA, Chen SP, Eikermann-Haerter K
    Current understanding of cortical structure and function in migraine.
    Cephalalgia. 2019 Mar 28:333102419840643. doi: 10.1177/0333102419840643.
    PubMed     Abstract available


  115. KIELBASA W, Helton DL
    A new era for migraine: Pharmacokinetic and pharmacodynamic insights into monoclonal antibodies with a focus on galcanezumab, an anti-CGRP antibody.
    Cephalalgia. 2019 Mar 27:333102419840780. doi: 10.1177/0333102419840780.
    PubMed     Abstract available


  116. CHONG CD, Peplinski J, Berisha V, Ross K, et al
    Differences in fibertract profiles between patients with migraine and those with persistent post-traumatic headache.
    Cephalalgia. 2019 Mar 26:333102418815650. doi: 10.1177/0333102418815650.
    PubMed     Abstract available


  117. ZHU B, Coppola G, Shoaran M
    Migraine classification using somatosensory evoked potentials.
    Cephalalgia. 2019 Mar 26:333102419839975. doi: 10.1177/0333102419839975.
    PubMed     Abstract available


  118. HAGEN K, Hopstock LA, Elise Eggen A, Mathiesen EB, et al
    Does insomnia modify the association between C-reactive protein and migraine? The Tromso Study 2015-2016.
    Cephalalgia. 2019 Mar 12:333102418825370. doi: 10.1177/0333102418825370.
    PubMed     Abstract available


  119. HOULE TT, Turner DP
    The vast potential of claims data to reduce undiagnosed chronic migraine.
    Cephalalgia. 2019 Mar 9:333102419836479. doi: 10.1177/0333102419836479.
    PubMed    


  120. PAVLOVIC JM, Yu JS, Silberstein SD, Reed ML, et al
    Development of a claims-based algorithm to identify potentially undiagnosed chronic migraine patients.
    Cephalalgia. 2019 Mar 9:333102418825373. doi: 10.1177/0333102418825373.
    PubMed     Abstract available


  121. LEREBOURS F, Boulanouar K, Barege M, Denuelle M, et al
    Functional connectivity of hypothalamus in chronic migraine with medication overuse.
    Cephalalgia. 2019 Mar 5:333102419833087. doi: 10.1177/0333102419833087.
    PubMed     Abstract available


  122. EDVINSSON L, Goadsby PJ
    Discovery of CGRP in relation to migraine.
    Cephalalgia. 2019;39:331-332.
    PubMed    


    February 2019
  123. BONAFEDE M, Wilson K, Xue F
    Long-term treatment patterns of prophylactic and acute migraine medications and incidence of opioid-related adverse events in patients with migraine.
    Cephalalgia. 2019 Feb 28:333102419835465. doi: 10.1177/0333102419835465.
    PubMed     Abstract available


  124. DIENER HC, Tassorelli C, Dodick DW, Silberstein SD, et al
    Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition.
    Cephalalgia. 2019 Feb 26:333102419828967. doi: 10.1177/0333102419828967.
    PubMed     Abstract available


  125. ABBASI M, Noori-Zadeh A, Seidkhani-Nahal A, Kaffashian M, et al
    Leptin, adiponectin, and resistin blood adipokine levels in migraineurs: Systematic reviews and meta-analyses.
    Cephalalgia. 2019 Feb 24:333102418807182. doi: 10.1177/0333102418807182.
    PubMed     Abstract available


  126. XU D, Chen D, Zhu LN, Tan G, et al
    Safety and tolerability of calcitonin-gene-related peptide binding monoclonal antibodies for the prevention of episodic migraine - a meta-analysis of randomized controlled trials.
    Cephalalgia. 2019 Feb 21:333102419829007. doi: 10.1177/0333102419829007.
    PubMed     Abstract available


  127. SENG EK, Gelfand AA, Nicholson RA
    Assessing evidence-based medicine and opioid/barbiturate as first-line acute treatment of pediatric migraine and primary headache: A retrospective observational study of health systems data.
    Cephalalgia. 2019 Feb 20:333102419833080. doi: 10.1177/0333102419833080.
    PubMed     Abstract available


  128. BOGDANOV VB, Bogdanova OV, Vigano A, Noirhomme Q, et al
    Increased cerebral responses to salient transitions between alternating stimuli in chronic migraine with medication overuse headache and during migraine attacks.
    Cephalalgia. 2019 Feb 20:333102418825359. doi: 10.1177/0333102418825359.
    PubMed     Abstract available


  129. LISICKI M, D'Ostilio K, Coppola G, Parisi V, et al
    Age related metabolic modifications in the migraine brain.
    Cephalalgia. 2019 Feb 11:333102419828984. doi: 10.1177/0333102419828984.
    PubMed     Abstract available


  130. DODICK DW, Reed ML, Fanning KM, Munjal S, et al
    Predictors of allodynia in persons with migraine: Results from the Migraine in America Symptoms and Treatment (MAST) study.
    Cephalalgia. 2019 Feb 7:333102418825346. doi: 10.1177/0333102418825346.
    PubMed     Abstract available


  131. BORTE S, Zwart JA, Stensland SO, Hagen K, et al
    Parental migraine in relation to migraine in offspring: Family linkage analyses from the HUNT Study.
    Cephalalgia. 2019 Feb 2:333102419828989. doi: 10.1177/0333102419828989.
    PubMed     Abstract available


    January 2019
  132. DODICK DW
    CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications.
    Cephalalgia. 2019 Jan 19:333102418821662. doi: 10.1177/0333102418821662.
    PubMed     Abstract available


  133. MARTAMI F, Togha M, Seifishahpar M, Ghorbani Z, et al
    The effects of a multispecies probiotic supplement on inflammatory markers and episodic and chronic migraine characteristics: A randomized double-blind controlled trial.
    Cephalalgia. 2019 Jan 8:333102418820102. doi: 10.1177/0333102418820102.
    PubMed     Abstract available


  134. HAJIHASHEMI P, Askari G, Khorvash F, Reza Maracy M, et al
    The effects of concurrent Coenzyme Q10, L-carnitine supplementation in migraine prophylaxis: A randomized, placebo-controlled, double-blind trial.
    Cephalalgia. 2019 Jan 6:333102418821661. doi: 10.1177/0333102418821661.
    PubMed     Abstract available


  135. INAN LE, Inan N, Unal-Artik HA, Atac C, et al
    Greater occipital nerve block in migraine prophylaxis: Narrative review.
    Cephalalgia. 2019 Jan 6:333102418821669. doi: 10.1177/0333102418821669.
    PubMed     Abstract available


  136. CHALMER MA, Hansen TF, Olesen J
    Nosographic analysis of osmophobia and field testing of diagnostic criteria including osmophobia.
    Cephalalgia. 2019;39:38-43.
    PubMed     Abstract available


  137. MAGGIONI F, Toldo G, Terrin A, Mainardi F, et al
    Simultaneous bilateral visual auras: A case report.
    Cephalalgia. 2019;39:162-163.
    PubMed    


    December 2018
  138. MAGON S, May A, Stankewitz A, Goadsby PJ, et al
    Cortical abnormalities in episodic migraine: A multi-center 3T MRI study.
    Cephalalgia. 2018 Dec 10:333102418795163. doi: 10.1177/0333102418795163.
    PubMed     Abstract available


    November 2018
  139. PETRUSIC I, Viana M, Dakovic M, J Goadsby P, et al
    Proposal for a Migraine Aura Complexity Score.
    Cephalalgia. 2018 Nov 20:333102418815487. doi: 10.1177/0333102418815487.
    PubMed     Abstract available


  140. CHOU DE, Shnayderman Yugrakh M, Winegarner D, Rowe V, et al
    Acute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial.
    Cephalalgia. 2018 Nov 17:333102418811573. doi: 10.1177/0333102418811573.
    PubMed     Abstract available


  141. SCHWEDT TJ, Peplinski J, Garcia-Filion P, Berisha V, et al
    Altered speech with migraine attacks: A prospective, longitudinal study of episodic migraine without aura.
    Cephalalgia. 2018 Nov 17:333102418815505. doi: 10.1177/0333102418815505.
    PubMed     Abstract available


    October 2018
  142. CARPENET C, Guichard E, Tzourio C, Kurth T, et al
    Self-perceived attention deficit and hyperactivity symptom levels and risk of non-migraine and migraine headaches among university students: A cross-sectional study.
    Cephalalgia. 2018 Oct 22:333102418804155. doi: 10.1177/0333102418804155.
    PubMed     Abstract available


  143. GOLLION C, Nasr N, Fabre N, Barege M, et al
    Cerebral autoregulation in migraine with aura: A case control study.
    Cephalalgia. 2018 Oct 8:333102418806861. doi: 10.1177/0333102418806861.
    PubMed     Abstract available


  144. NATION KM, Dodick DW, Navratilova E, Porreca F, et al
    Sustained exposure to acute migraine medications combined with repeated noxious stimulation dysregulates descending pain modulatory circuits: Relevance to medication overuse headache.
    Cephalalgia. 2018 Oct 4:333102418804157. doi: 10.1177/0333102418804157.
    PubMed     Abstract available


    September 2018
  145. VO P, Wen S, Martel MJ, Mitsikostas D, et al
    Benefit-risk assessment of erenumab and current migraine prophylactic treatments using the likelihood of being helped or harmed.
    Cephalalgia. 2018 Sep 19:333102418801579. doi: 10.1177/0333102418801579.
    PubMed     Abstract available


  146. GRAZZI L, Raggi A, D'Amico D, Sansone E, et al
    A prospective pilot study of the effect on catecholamines of mindfulness training vs pharmacological prophylaxis in patients with chronic migraine and medication overuse headache.
    Cephalalgia. 2018 Sep 13:333102418801584. doi: 10.1177/0333102418801584.
    PubMed     Abstract available


    August 2018
  147. VOLLESEN LH, Guo S, Andersen MR, Ashina M, et al
    Effect of the H1-antihistamine clemastine on PACAP38 induced migraine.
    Cephalalgia. 2018 Aug 30:333102418798611. doi: 10.1177/0333102418798611.
    PubMed     Abstract available


  148. SUSSMAN M, Benner J, Neumann P, Menzin J, et al
    Cost-effectiveness analysis of erenumab for the preventive treatment of episodic and chronic migraine: Results from the US societal and payer perspectives.
    Cephalalgia. 2018 Aug 24:333102418796842. doi: 10.1177/0333102418796842.
    PubMed     Abstract available


  149. LAURITSEN CG, Silberstein SD
    Rationale for electrical parameter determination in external trigeminal nerve stimulation (eTNS) for migraine: A narrative review.
    Cephalalgia. 2018 Aug 23:333102418796781. doi: 10.1177/0333102418796781.
    PubMed     Abstract available


  150. FUGLSANG CH, Johansen T, Kaila K, Kasch H, et al
    Treatment of acute migraine by a partial rebreathing device: A randomized controlled pilot study.
    Cephalalgia. 2018 Aug 22:333102418797285. doi: 10.1177/0333102418797285.
    PubMed     Abstract available


  151. STARIKOVA NL, Baidina TV, Kalashnikova TP
    Thyrotropin levels and severity of symptoms in migraine patients of tertiary headache center.
    Cephalalgia. 2018 Aug 13:333102418794941. doi: 10.1177/0333102418794941.
    PubMed     Abstract available


  152. PARK JH, Park KA, Cha J, Kim ST, et al
    A case report of isolated orbital vasculitis mimicking retinal migraine: A potential cause of recurrent transient monocular blindness and ipsilateral headache.
    Cephalalgia. 2018 Aug 12:333102418794482. doi: 10.1177/0333102418794482.
    PubMed     Abstract available


  153. STRUPF M, Fraunberger B, Messlinger K, Namer B, et al
    Cyclic changes in sensations to painful stimuli in migraine patients.
    Cephalalgia. 2018 Aug 12:333102418793641. doi: 10.1177/0333102418793641.
    PubMed     Abstract available


  154. PELLERIN A, Marois C, Mezouar N, Mokhtari K, et al
    Neuronal injuries evidenced by transient cortical magnetic resonance enhancement in hemiplegic migraine: A case report.
    Cephalalgia. 2018 Aug 9:333102418794481. doi: 10.1177/0333102418794481.
    PubMed     Abstract available


  155. DEEN M, Hougaard A, Hansen HD, Svarer C, et al
    Migraine is associated with high brain 5-HT levels as indexed by 5-HT4 receptor binding.
    Cephalalgia. 2018 Aug 8:333102418793642. doi: 10.1177/0333102418793642.
    PubMed     Abstract available


  156. BUSE DC, Lipton RB, Hallstrom Y, Reuter U, et al
    Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab.
    Cephalalgia. 2018 Aug 7:333102418789072. doi: 10.1177/0333102418789072.
    PubMed     Abstract available


  157. ALBERS L, von Kries R, Straube A, Heinen F, et al
    Do pre-school episodic syndromes predict migraine in primary school children? A retrospective cohort study on health care data.
    Cephalalgia. 2018 Aug 4:333102418791820. doi: 10.1177/0333102418791820.
    PubMed     Abstract available


  158. YOUNIS S, Hougaard A, Noseda R, Ashina M, et al
    Current understanding of thalamic structure and function in migraine.
    Cephalalgia. 2018 Aug 4:333102418791595. doi: 10.1177/0333102418791595.
    PubMed     Abstract available


    May 2018
  159. RAMACHANDRAN R, Pedersen SH, Amrutkar DV, Petersen S, et al
    Selective cephalic upregulation of p-ERK, CamKII and p-CREB in response to glyceryl trinitrate infusion.
    Cephalalgia. 2018;38:1057-1070.
    PubMed     Abstract available


    April 2018
  160. FRIED NT, Maxwell CR, Elliott MB, Oshinsky ML, et al
    Region-specific disruption of the blood-brain barrier following repeated inflammatory dural stimulation in a rat model of chronic trigeminal allodynia.
    Cephalalgia. 2018;38:674-689.
    PubMed     Abstract available


  161. GOADSBY PJ, Dodick DW, Lipton RB
    Re: Placebo responses in device studies.
    Cephalalgia. 2018;38:1007-1008.
    PubMed    


    February 2018
  162. BRILLA R, Pawlowski M, Evers S
    Hemicrania continua in carotid artery dissection - symptomatic cases or linked pathophysiology?
    Cephalalgia. 2018;38:402-405.
    PubMed     Abstract available


  163. ASHINA H, Schytz HW, Ashina M
    CGRP in human models of primary headaches.
    Cephalalgia. 2018;38:353-360.
    PubMed     Abstract available


  164. ZANCHIN G, Fuccaro M, Battistella P, Ermani M, et al
    A lost track in ICHD 3 beta: A comprehensive review on osmophobia.
    Cephalalgia. 2018;38:340-352.
    PubMed     Abstract available


    January 2018
  165. OAKES TMM, Skljarevsuki V, Zhang Q, Kielbasa W, et al
    Safety of galcanezumab in patients with episodic migraine: A randomized placebo-controlled dose-ranging Phase 2b study.
    Cephalalgia. 2018 Jan 1:333102417747230. doi: 10.1177/0333102417747230.
    PubMed     Abstract available


  166. KROLL LS, Hammarlund CS, Linde M, Gard G, et al
    The effects of aerobic exercise for persons with migraine and co-existing tension-type headache and neck pain. A randomized, controlled, clinical trial.
    Cephalalgia. 2018 Jan 1:333102417752119. doi: 10.1177/0333102417752119.
    PubMed     Abstract available


  167. KROS L, Angueyra Aristizabal CA, Khodakhah K
    Cerebellar involvement in migraine.
    Cephalalgia. 2018 Jan 1:333102417752120. doi: 10.1177/0333102417752120.
    PubMed     Abstract available


  168. RIST PM, Winter AC, Buring JE, Sesso HD, et al
    Migraine and the risk of incident hypertension among women.
    Cephalalgia. 2018 Jan 1:333102418756865. doi: 10.1177/0333102418756865.
    PubMed     Abstract available


  169. SANTANGELO G, Russo A, Tessitore A, Garramone F, et al
    Prospective memory is dysfunctional in migraine without aura.
    Cephalalgia. 2018 Jan 1:333102418758280. doi: 10.1177/0333102418758280.
    PubMed     Abstract available


  170. HOLLAND PR, Saengjaroentham C, Vila-Pueyo M
    The role of the brainstem in migraine: Potential brainstem effects of CGRP and CGRP receptor activation in animal models.
    Cephalalgia. 2018 Jan 1:333102418756863. doi: 10.1177/0333102418756863.
    PubMed     Abstract available


  171. TFELT-HANSEN P, Lindqvist JK, Do TP
    Evaluating the reporting of adverse events in controlled clinical trials conducted in 2010-2015 on migraine drug treatments.
    Cephalalgia. 2018 Jan 1:333102418759785. doi: 10.1177/0333102418759785.
    PubMed     Abstract available


  172. HIEKKALA ME, Vuola P, Artto V, Happola P, et al
    The contribution of CACNA1A, ATP1A2 and SCN1A mutations in hemiplegic migraine: A clinical and genetic study in Finnish migraine families.
    Cephalalgia. 2018 Jan 1:333102418761041. doi: 10.1177/0333102418761041.
    PubMed     Abstract available


  173. DODICK DW, Ashina M, Brandes JL, Kudrow D, et al
    ARISE: A Phase 3 randomized trial of erenumab for episodic migraine.
    Cephalalgia. 2018 Jan 1:333102418759786. doi: 10.1177/0333102418759786.
    PubMed     Abstract available


  174. HAGEN K, Asberg AN, Stovner L, Linde M, et al
    Lifestyle factors and risk of migraine and tension-type headache. Follow-up data from the Nord-Trondelag Health Surveys 1995-1997 and 2006-2008.
    Cephalalgia. 2018 Jan 1:333102418764888. doi: 10.1177/0333102418764888.
    PubMed     Abstract available


  175. STARLING AJ, Tepper SJ, Marmura MJ, Shamim EA, et al
    A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study).
    Cephalalgia. 2018 Jan 1:333102418762525. doi: 10.1177/0333102418762525.
    PubMed     Abstract available


  176. TASSORELLI C, Diener HC, Dodick DW, Silberstein SD, et al
    Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults.
    Cephalalgia. 2018 Jan 1:333102418758283. doi: 10.1177/0333102418758283.
    PubMed     Abstract available


  177. ERDAL Y, Emre U, Cimen Atalar A, Gunes T, et al
    Alien hand syndrome and migraine with aura: A case report.
    Cephalalgia. 2018 Jan 1:333102418763321. doi: 10.1177/0333102418763321.
    PubMed     Abstract available


  178. RENTHAL W
    Localization of migraine susceptibility genes in human brain by single-cell RNA sequencing.
    Cephalalgia. 2018 Jan 1:333102418762476. doi: 10.1177/0333102418762476.
    PubMed     Abstract available


  179. GHANIZADA H, Arngrim N, Schytz HW, Olesen J, et al
    Carbon monoxide inhalation induces headache but no migraine in patients with migraine without aura.
    Cephalalgia. 2018 Jan 1:333102418765771. doi: 10.1177/0333102418765771.
    PubMed     Abstract available


  180. EVANS RW
    Episodic daily migraine or episodic status migrainosus.
    Cephalalgia. 2018 Jan 1:333102418766869. doi: 10.1177/0333102418766869.
    PubMed    


  181. GELFAND JM, Gelfand AA, Goadsby PJ, Benn BS, et al
    Migraine is common in patients with sarcoidosis.
    Cephalalgia. 2018 Jan 1:333102418768037. doi: 10.1177/0333102418768037.
    PubMed     Abstract available


  182. MESSINA R, Goadsby PJ
    CGRP - a target for acute therapy in migraine: Clinical data.
    Cephalalgia. 2018 Jan 1:333102418768095. doi: 10.1177/0333102418768095.
    PubMed     Abstract available


  183. CARVALHO GF, Vianna-Bell FH, Florencio LL, Pinheiro CF, et al
    Presence of vestibular symptoms and related disability in migraine with and without aura and chronic migraine.
    Cephalalgia. 2018 Jan 1:333102418769948. doi: 10.1177/0333102418769948.
    PubMed     Abstract available


  184. RAMSEY RR, Holbein CE, Powers SW, Hershey AD, et al
    A pilot investigation of a mobile phone application and progressive reminder system to improve adherence to daily prevention treatment in adolescents and young adults with migraine.
    Cephalalgia. 2018 Jan 1:333102418756864. doi: 10.1177/0333102418756864.
    PubMed     Abstract available


  185. VIANA M, Bottiroli S, Sances G, Ghiotto N, et al
    Factors associated to chronic migraine with medication overuse: A cross-sectional study.
    Cephalalgia. 2018 Jan 1:333102418761047. doi: 10.1177/0333102418761047.
    PubMed     Abstract available


  186. AHMED M, Boyd C, Vavilikolanu R, Rafique B, et al
    Visual symptoms and childhood migraine: Qualitative analysis of duration, location, spread, mobility, colour and pattern.
    Cephalalgia. 2018 Jan 1:333102418766872. doi: 10.1177/0333102418766872.
    PubMed     Abstract available


  187. TERRIN A, Toldo G, Ermani M, Mainardi F, et al
    When migraine mimics stroke: A systematic review.
    Cephalalgia. 2018 Jan 1:333102418767999. doi: 10.1177/0333102418767999.
    PubMed     Abstract available


  188. PURDY RA, Diener HC
    Migraine mimicking stroke: What to do?
    Cephalalgia. 2018 Jan 1:333102418768087. doi: 10.1177/0333102418768087.
    PubMed    


  189. CLOSE LN, Eftekhari S, Wang M, Charles AC, et al
    Cortical spreading depression as a site of origin for migraine: Role of CGRP.
    Cephalalgia. 2018 Jan 1:333102418774299. doi: 10.1177/0333102418774299.
    PubMed     Abstract available


  190. ANGUS-LEPPAN H, Caulfield A
    Orgasmic migraine aura: Report of two cases.
    Cephalalgia. 2018 Jan 1:333102418771373. doi: 10.1177/0333102418771373.
    PubMed     Abstract available


  191. RUBINO E, Rainero I, Garino F, Vicentini C, et al
    Subclinical hypothyroidism is associated with migraine: A case-control study.
    Cephalalgia. 2018 Jan 1:333102418769917. doi: 10.1177/0333102418769917.
    PubMed     Abstract available


  192. HALKER SINGH RB, Aycardi E, Bigal ME, Loupe PS, et al
    Sustained reductions in migraine days, moderate-to-severe headache days and days with acute medication use for HFEM and CM patients taking fremanezumab: Post-hoc analyses from phase 2 trials.
    Cephalalgia. 2018 Jan 1:333102418772585. doi: 10.1177/0333102418772585.
    PubMed     Abstract available


  193. LEVINSKY Y, Zeharia A, Eidlitz-Markus T
    Cephalic cutaneous allodynia in children and adolescents with migraine of short duration: A retrospective cohort study.
    Cephalalgia. 2018 Jan 1:333102418776018. doi: 10.1177/0333102418776018.
    PubMed     Abstract available


  194. MOYE LS, Novack ML, Tipton AF, Krishnan H, et al
    The development of a mouse model of mTBI-induced post-traumatic migraine, and identification of the delta opioid receptor as a novel therapeutic target.
    Cephalalgia. 2018 Jan 1:333102418777507. doi: 10.1177/0333102418777507.
    PubMed     Abstract available


  195. MARTINS LB, Rodrigues AMDS, Rodrigues DF, Dos Santos LC, et al
    Double-blind placebo-controlled randomized clinical trial of ginger ( Zingiber officinale Rosc.) addition in migraine acute treatment.
    Cephalalgia. 2018 Jan 1:333102418776016. doi: 10.1177/0333102418776016.
    PubMed     Abstract available


  196. DE HOON J, Van Hecken A, Vandermeulen C, Herbots M, et al
    Phase 1, randomized, parallel-group, double-blind, placebo-controlled trial to evaluate the effects of erenumab (AMG 334) and concomitant sumatriptan on blood pressure in healthy volunteers.
    Cephalalgia. 2018 Jan 1:333102418776017. doi: 10.1177/0333102418776017.
    PubMed     Abstract available


  197. HASSLER SN, Ahmad FB, Burgos-Vega CC, Boitano S, et al
    Protease activated receptor 2 (PAR2) activation causes migraine-like pain behaviors in mice.
    Cephalalgia. 2018 Jan 1:333102418779548. doi: 10.1177/0333102418779548.
    PubMed     Abstract available


  198. BURGOS-VEGA CC, Quigley LD, Trevisan Dos Santos G, Yan F, et al
    Non-invasive dural stimulation in mice: A novel preclinical model of migraine.
    Cephalalgia. 2018 Jan 1:333102418779557. doi: 10.1177/0333102418779557.
    PubMed     Abstract available


  199. SKLJAREVSKI V, Matharu M, Millen BA, Ossipov MH, et al
    Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial.
    Cephalalgia. 2018 Jan 1:333102418779543. doi: 10.1177/0333102418779543.
    PubMed     Abstract available


  200. ABDOLLAHPOUR I, Salimi Y
    Subclinical hypothyroidism is associated with migraine: A case-control study; methodological and statistical issues.
    Cephalalgia. 2018 Jan 1:333102418779542. doi: 10.1177/0333102418779542.
    PubMed    


  201. CORTESE F, Pierelli F, Pauri F, Di Lorenzo C, et al
    Short-term cortical synaptic depression/potentiation mechanisms in chronic migraine patients with or without medication overuse.
    Cephalalgia. 2018 Jan 1:333102418784747. doi: 10.1177/0333102418784747.
    PubMed     Abstract available


  202. PELZER N, Louter MA, van Zwet EW, Nyholt DR, et al
    Linking migraine frequency with family history of migraine.
    Cephalalgia. 2018 Jan 1:333102418783295. doi: 10.1177/0333102418783295.
    PubMed     Abstract available


  203. LEVY D, Labastida-Ramirez A, MaassenVanDenBrink A
    Current understanding of meningeal and cerebral vascular function underlying migraine headache.
    Cephalalgia. 2018 Jan 1:333102418771350. doi: 10.1177/0333102418771350.
    PubMed     Abstract available


  204. SCHER AI, Wang SJ, Katsarava Z, Buse DC, et al
    Epidemiology of migraine in men: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
    Cephalalgia. 2018 Jan 1:333102418786266. doi: 10.1177/0333102418786266.
    PubMed     Abstract available


  205. ANTONACI F, Rossi E, Voiticovschi-Iosob C, Dalla Volta G, et al
    Frontal infrared thermography in healthy individuals and chronic migraine patients: Reliability of the method.
    Cephalalgia. 2018 Jan 1:333102418788341. doi: 10.1177/0333102418788341.
    PubMed     Abstract available


  206. BERTELLI S, Barbieri R, Pusch M, Gavazzo P, et al
    Gain of function of sporadic/familial hemiplegic migraine-causing SCN1A mutations: Use of an optimized cDNA.
    Cephalalgia. 2018 Jan 1:333102418788336. doi: 10.1177/0333102418788336.
    PubMed     Abstract available


  207. ASHINA M, Tepper S, Brandes JL, Reuter U, et al
    Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study.
    Cephalalgia. 2018 Jan 1:333102418788347. doi: 10.1177/0333102418788347.
    PubMed     Abstract available


  208. PLATZBECKER K, Zhang MB, Kurth T, Rudolph MI, et al
    The association between migraine and hospital readmission due to pain after surgery: A hospital registry study.
    Cephalalgia. 2018 Jan 1:333102418786457. doi: 10.1177/0333102418786457.
    PubMed     Abstract available


  209. SEAV SM, Schuster NM
    Cluster-status migrainosus with a weekly periodicity responsive to high-flow oxygen: A case report.
    Cephalalgia. 2018 Jan 1:333102418787263. doi: 10.1177/0333102418787263.
    PubMed     Abstract available


    May 2017
  210. HANSEN AG, Stovner LJ, Hagen K, Helvik AS, et al
    Paranasal sinus opacification in headache sufferers: A population-based imaging study (the HUNT study-MRI).
    Cephalalgia. 2017;37:509-516.
    PubMed     Abstract available


    April 2017
  211. BRITZE J, Arngrim N, Schytz HW, Ashina M, et al
    Hypoxic mechanisms in primary headaches.
    Cephalalgia. 2017;37:372-384.
    PubMed     Abstract available


    February 2017
  212. PIOVESAN EJ, Kowacs PA
    A path for two destinations.
    Cephalalgia. 2017;37:199.
    PubMed    


    January 2017
  213. PRONTERA P, Sarchielli P, Caproni S, Bedetti C, et al
    Epilepsy in hemiplegic migraine: Genetic mutations and clinical implications.
    Cephalalgia. 2017 Jan 1:333102416686347. doi: 10.1177/0333102416686347.
    PubMed     Abstract available


  214. GERRING ZF, Powell JE, Montgomery GW, Nyholt DR, et al
    Genome-wide analysis of blood gene expression in migraine implicates immune-inflammatory pathways.
    Cephalalgia. 2017 Jan 1:333102416686769. doi: 10.1177/0333102416686769.
    PubMed     Abstract available


  215. SINGH TD, Cutrer FM, Smith JH
    Episodic status migrainosus: A novel migraine subtype.
    Cephalalgia. 2017 Jan 1:333102416686341. doi: 10.1177/0333102416686341.
    PubMed     Abstract available


  216. DE AMORIM IL, Antunes AP, Nunes GS, Martins IP, et al
    Reversible cortical thickening in hemiplegic migraine.
    Cephalalgia. 2017 Jan 1:333102417690128. doi: 10.1177/0333102417690128.
    PubMed    


  217. TAGA A, Russo M, Genovese A, Manzoni GC, et al
    A case-report of migraine "sine headache".
    Cephalalgia. 2017 Jan 1:333102417690892. doi: 10.1177/0333102417690892.
    PubMed     Abstract available


  218. RAMOS ML, Garcia-Cabo C, Leira R, Dominguez C, et al
    Comorbidity between idiopathic overactive bladder and chronic migraine.
    Cephalalgia. 2017 Jan 1:333102417690127. doi: 10.1177/0333102417690127.
    PubMed     Abstract available


  219. HAGEN K, Asvold BO, Midthjell K, Stovner LJ, et al
    Inverse relationship between type 1 diabetes mellitus and migraine. Data from the Nord-Trondelag Health Surveys 1995-1997 and 2006-2008.
    Cephalalgia. 2017 Jan 1:333102417690488. doi: 10.1177/0333102417690488.
    PubMed     Abstract available


  220. CHAUVEL V, Multon S, Schoenen J
    Estrogen-dependent effects of 5-hydroxytryptophan on cortical spreading depression in rat: Modelling the serotonin-ovarian hormone interaction in migraine aura.
    Cephalalgia. 2017 Jan 1:333102417690891. doi: 10.1177/0333102417690891.
    PubMed     Abstract available


  221. MCILVRIED LA, Cruz JA, Borghesi LA, Gold MS, et al
    Sex-, stress-, and sympathetic post-ganglionic-dependent changes in identity and proportions of immune cells in the dura.
    Cephalalgia. 2017;37:36-48.
    PubMed     Abstract available


  222. CORTEZ MM, Rea NA, Hunter LA, Digre KB, et al
    Altered pupillary light response scales with disease severity in migrainous photophobia.
    Cephalalgia. 2017 Jan 1:333102416673205. doi: 10.1177/0333102416673205.
    PubMed     Abstract available


  223. PALM-MEINDERS IH, Koppen H, Terwindt GM, Launer LJ, et al
    Iron in deep brain nuclei in migraine? CAMERA follow-up MRI findings.
    Cephalalgia. 2017 Jan 1:333102416668654. doi: 10.1177/0333102416668654.
    PubMed     Abstract available


  224. XIE JY, De Felice M, Kopruszinski CM, Eyde N, et al
    Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention.
    Cephalalgia. 2017 Jan 1:333102417702120. doi: 10.1177/0333102417702120.
    PubMed     Abstract available


  225. LEBEDEVA ER, Gurary NM, Gilev DV, Olesen J, et al
    Prospective testing of ICHD-3 beta diagnostic criteria for migraine with aura and migraine with typical aura in patients with transient ischemic attacks.
    Cephalalgia. 2017 Jan 1:333102417702121. doi: 10.1177/0333102417702121.
    PubMed     Abstract available


  226. SILVA-NETO RP, Rodrigues AB, Cavalcante DC, Ferreira PHPB, et al
    Reply to the Letter to the Editor: "Smell of migraine: Osmophobia as a clinical diagnostic marker".
    Cephalalgia. 2017 Jan 1:333102416658716. doi: 10.1177/0333102416658716.
    PubMed    


  227. WEN KX, Mutlu U, Ikram MK, Kavousi M, et al
    The retinal microcirculation in migraine: The Rotterdam Study.
    Cephalalgia. 2017 Jan 1:333102417708774. doi: 10.1177/0333102417708774.
    PubMed     Abstract available


  228. SAMPAIO ROCHA-FILHO PA
    Episodic status migrainosus: One more case.
    Cephalalgia. 2017 Jan 1:333102417710021. doi: 10.1177/0333102417710021.
    PubMed    


  229. GOULART AC, Lotufo PA, Santos IS, Bittencourt MS, et al
    The relationship between migraine and lipid sub-fractions among individuals without cardiovascular disease: A cross-sectional evaluation in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
    Cephalalgia. 2017 Jan 1:333102417699181. doi: 10.1177/0333102417699181.
    PubMed     Abstract available


  230. MYKLAND MS, Bjork MH, Stjern M, Sand T, et al
    Alterations in post-movement beta event related synchronization throughout the migraine cycle: A controlled, longitudinal study.
    Cephalalgia. 2017 Jan 1:333102417709011. doi: 10.1177/0333102417709011.
    PubMed     Abstract available


  231. MARTIN VT, Allen JR, Houle TT, Powers SW, et al
    Ovarian hormones, age and pubertal development and their association with days of headache onset in girls with migraine: An observational cohort study.
    Cephalalgia. 2017 Jan 1:333102417706980. doi: 10.1177/0333102417706980.
    PubMed     Abstract available


  232. WANG SB, Liu KD, Yang Y, Li YJ, et al
    Prevalence and extent of right-to-left shunt on contrast-enhanced transcranial Doppler in Chinese patients with migraine in a multicentre case-control study.
    Cephalalgia. 2017 Jan 1:333102417708203. doi: 10.1177/0333102417708203.
    PubMed     Abstract available


  233. HSIAO FJ, Wang SJ, Lin YY, Fuh JL, et al
    Somatosensory gating is altered and associated with migraine chronification: A magnetoencephalographic study.
    Cephalalgia. 2017 Jan 1:333102417712718. doi: 10.1177/0333102417712718.
    PubMed     Abstract available


  234. DALLEL R, Descheemaeker A, Luccarini P
    Recurrent administration of the nitric oxide donor, isosorbide dinitrate, induces a persistent cephalic cutaneous hypersensitivity: A model for migraine progression.
    Cephalalgia. 2017 Jan 1:333102417714032. doi: 10.1177/0333102417714032.
    PubMed     Abstract available


  235. WARHURST S, Rofe CJ, Brew BJ, Bateson D, et al
    Effectiveness of the progestin-only pill for migraine treatment in women: A systematic review and meta-analysis.
    Cephalalgia. 2017 Jan 1:333102417710636. doi: 10.1177/0333102417710636.
    PubMed     Abstract available


  236. KAYAMA Y, Shibata M, Takizawa T, Ibata K, et al
    Functional interactions between transient receptor potential M8 and transient receptor potential V1 in the trigeminal system: Relevance to migraine pathophysiology.
    Cephalalgia. 2017 Jan 1:333102417712719. doi: 10.1177/0333102417712719.
    PubMed     Abstract available


  237. COPPOLA G, Di Renzo A, Tinelli E, Di Lorenzo C, et al
    Resting state connectivity between default mode network and insula encodes acute migraine headache.
    Cephalalgia. 2017 Jan 1:333102417715230. doi: 10.1177/0333102417715230.
    PubMed     Abstract available


  238. SONG TJ, Yun CH, Cho SJ, Kim WJ, et al
    Short sleep duration and poor sleep quality among migraineurs: A population-based study.
    Cephalalgia. 2017 Jan 1:333102417716936. doi: 10.1177/0333102417716936.
    PubMed     Abstract available


  239. LUEDTKE K, Starke W, May A
    Musculoskeletal dysfunction in migraine patients.
    Cephalalgia. 2017 Jan 1:333102417716934. doi: 10.1177/0333102417716934.
    PubMed     Abstract available


  240. CHARLESTON IV L, Burke JF
    Do racial/ethnic disparities exist in recommended migraine treatments in US ambulatory care?
    Cephalalgia. 2017 Jan 1:333102417716933. doi: 10.1177/0333102417716933.
    PubMed     Abstract available


  241. DOMINGUEZ C, Vieites-Prado A, Perez-Mato M, Sobrino T, et al
    Role of adipocytokines in the pathophysiology of migraine. A cross-sectional study.
    Cephalalgia. 2017 Jan 1:333102417720213. doi: 10.1177/0333102417720213.
    PubMed     Abstract available


  242. KHAN S, Deen M, Hougaard A, Amin FM, et al
    Reproducibility of migraine-like attacks induced by phosphodiesterase-3-inhibitor cilostazol.
    Cephalalgia. 2017 Jan 1:333102417719753. doi: 10.1177/0333102417719753.
    PubMed     Abstract available


  243. LISICKI M, Ruiz-Romagnoli E, Piedrabuena R, Giobellina R, et al
    Migraine triggers and habituation of visual evoked potentials.
    Cephalalgia. 2017 Jan 1:333102417720217. doi: 10.1177/0333102417720217.
    PubMed     Abstract available


  244. KRISTOFFERSEN ES, Stavem K, Lundqvist C, Russell MB, et al
    Excessive daytime sleepiness in chronic migraine and chronic tension-type headache from the general population.
    Cephalalgia. 2017 Jan 1:333102417721133. doi: 10.1177/0333102417721133.
    PubMed     Abstract available


  245. VINOGRADOVA LV
    Initiation of spreading depression by synaptic and network hyperactivity: Insights into trigger mechanisms of migraine aura.
    Cephalalgia. 2017 Jan 1:333102417724151. doi: 10.1177/0333102417724151.
    PubMed     Abstract available


  246. PELZER N, Hoogeveen ES, Ferrari MD, Poll-The BT, et al
    Brain atrophy following hemiplegic migraine attacks.
    Cephalalgia. 2017 Jan 1:333102417723569. doi: 10.1177/0333102417723569.
    PubMed     Abstract available


  247. BUONFIGLIO M, Di Sabato F
    Lack of habituation of visual evoked potentials in migraine and healthy subjects: Correlated cognitive behavioral aspects.
    Cephalalgia. 2017 Jan 1:333102417724153. doi: 10.1177/0333102417724153.
    PubMed    


  248. CADIOT D, Longuet R, Bruneau B, Treguier C, et al
    Magnetic resonance imaging in children presenting migraine with aura: Association of hypoperfusion detected by arterial spin labelling and vasospasm on MR angiography findings.
    Cephalalgia. 2017 Jan 1:333102417723570. doi: 10.1177/0333102417723570.
    PubMed     Abstract available


  249. DEEN M, Hansen HD, Hougaard A, da Cunha-Bang S, et al
    Low 5-HT1B receptor binding in the migraine brain: A PET study.
    Cephalalgia. 2017 Jan 1:333102417698708. doi: 10.1177/0333102417698708.
    PubMed     Abstract available


  250. MAMOURI O, Cuvellier JC, Duhamel A, Vallee L, et al
    Postdrome symptoms in pediatric migraine: A questionnaire retrospective study by phone in 100 patients.
    Cephalalgia. 2017 Jan 1:333102417721132. doi: 10.1177/0333102417721132.
    PubMed     Abstract available


  251. WILCOX SL, Ludwick AM, Lebel A, Borsook D, et al
    Age- and sex-related differences in the presentation of paediatric migraine: A retrospective cohort study.
    Cephalalgia. 2017 Jan 1:333102417722570. doi: 10.1177/0333102417722570.
    PubMed     Abstract available


  252. VOLLONO C, Primiano G, Della Marca G, Losurdo A, et al
    Migraine in mitochondrial disorders: Prevalence and characteristics.
    Cephalalgia. 2017 Jan 1:333102417723568. doi: 10.1177/0333102417723568.
    PubMed     Abstract available


  253. SPIELMANN K, Kayser A, Beck E, Meister R, et al
    Pregnancy outcome after anti-migraine triptan use: A prospective observational cohort study.
    Cephalalgia. 2017 Jan 1:333102417724152. doi: 10.1177/0333102417724152.
    PubMed     Abstract available


  254. MATHARU M, Pascual J, Nilsson Remahl I, Straube A, et al
    Utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine from an observational study in Europe.
    Cephalalgia. 2017 Jan 1:333102417724150. doi: 10.1177/0333102417724150.
    PubMed     Abstract available


  255. GRECO R, Demartini C, Zanaboni AM, Berliocchi L, et al
    Inhibition of monoacylglycerol lipase: Another signalling pathway for potential therapeutic targets in migraine?
    Cephalalgia. 2017 Jan 1:333102417727537. doi: 10.1177/0333102417727537.
    PubMed     Abstract available


  256. ZHAO Y, Martins-Oliveira M, Akerman S, Goadsby PJ, et al
    Comparative effects of traditional Chinese and Western migraine medicines in an animal model of nociceptive trigeminovascular activation.
    Cephalalgia. 2017 Jan 1:333102417728245. doi: 10.1177/0333102417728245.
    PubMed     Abstract available


  257. GUY N, Voisin D, Mulliez A, Clavelou P, et al
    Medication overuse reinstates conditioned pain modulation in women with migraine.
    Cephalalgia. 2017 Jan 1:333102417727545. doi: 10.1177/0333102417727545.
    PubMed     Abstract available


  258. INDELICATO E, Nachbauer W, Eigentler A, Donnemiller E, et al
    Ten years of follow-up in a large family with familial hemiplegic migraine type 1: Clinical course and implications for treatment.
    Cephalalgia. 2017 Jan 1:333102417715229. doi: 10.1177/0333102417715229.
    PubMed     Abstract available


  259. VECCHIO E, Gentile E, Franco G, Ricci K, et al
    Effects of external trigeminal nerve stimulation (eTNS) on laser evoked cortical potentials (LEP): A pilot study in migraine patients and controls.
    Cephalalgia. 2017 Jan 1:333102417728748. doi: 10.1177/0333102417728748.
    PubMed     Abstract available


  260. GUERRERO-PERAL AL, Ruiz M, Baron J, Palacios-Cena M, et al
    Roller pressure algometry as a new tool for assessing dynamic pressure sensitivity in migraine.
    Cephalalgia. 2017 Jan 1:333102417729114. doi: 10.1177/0333102417729114.
    PubMed     Abstract available


  261. LISICKI M, D'Ostilio K, Erpicum M, Schoenen J, et al
    Sunlight irradiance and habituation of visual evoked potentials in migraine: The environment makes its mark.
    Cephalalgia. 2017 Jan 1:333102417730128. doi: 10.1177/0333102417730128.
    PubMed     Abstract available


  262. AMIN FM, Hougaard A, Magon S, Sprenger T, et al
    Altered thalamic connectivity during spontaneous attacks of migraine without aura: A resting-state fMRI study.
    Cephalalgia. 2017 Jan 1:333102417729113. doi: 10.1177/0333102417729113.
    PubMed     Abstract available


  263. CHENG CY, Cheng HM, Chen SP, Chung CP, et al
    White matter hyperintensities in migraine: Clinical significance and central pulsatile hemodynamic correlates.
    Cephalalgia. 2017 Jan 1:333102417728751. doi: 10.1177/0333102417728751.
    PubMed     Abstract available


  264. GIL-GOUVEIA R, Martins IP
    Clinical description of attack-related cognitive symptoms in migraine: A systematic review.
    Cephalalgia. 2017 Jan 1:333102417728250. doi: 10.1177/0333102417728250.
    PubMed     Abstract available


  265. TIETJEN GE, Khubchandani J, Herial N, Palm-Meinders IH, et al
    Migraine and vascular disease biomarkers: A population-based case-control study.
    Cephalalgia. 2017 Jan 1:333102417698936. doi: 10.1177/0333102417698936.
    PubMed     Abstract available


  266. MIN HJ, Kim KS
    Comment on: Role of adipocytokines in the pathophysiology of migraine. A cross-sectional study.
    Cephalalgia. 2017 Jan 1:333102417731350. doi: 10.1177/0333102417731350.
    PubMed    


  267. MIN HJ, Kim KS
    Comment on: Relationship between serum levels of VIP, but not of CGRP, and cranial autonomic parasympathetic symptoms: A study in chronic migraine patients.
    Cephalalgia. 2017 Jan 1:333102417731352. doi: 10.1177/0333102417731352.
    PubMed    


  268. MIN HJ, Kim KS
    Comment on: Excessive daytime sleepiness in chronic migraine and chronic tension-type headache from the general population.
    Cephalalgia. 2017 Jan 1:333102417731354. doi: 10.1177/0333102417731354.
    PubMed    


  269. CHRISTENSEN CE, Andersen FS, Wienholtz N, Egeberg A, et al
    The relationship between migraine and rosacea: Systematic review and meta-analysis.
    Cephalalgia. 2017 Jan 1:333102417731777. doi: 10.1177/0333102417731777.
    PubMed     Abstract available


  270. CAO Z, Lai KL, Lin CT, Chuang CH, et al
    Exploring resting-state EEG complexity before migraine attacks.
    Cephalalgia. 2017 Jan 1:333102417733953. doi: 10.1177/0333102417733953.
    PubMed     Abstract available


  271. OMLAND PM, Uglem M, Stovner LJ, Sand T, et al
    Visual and auditory cortical evoked potentials in interictal episodic migraine: The predictive value of a proposed diagnostic test should always be corrected for prevalence.
    Cephalalgia. 2017 Jan 1:333102417695797. doi: 10.1177/0333102417695797.
    PubMed    


  272. MARCISZEWSKI KK, Meylakh N, Di Pietro F, Macefield VG, et al
    Altered brainstem anatomy in migraine.
    Cephalalgia. 2017 Jan 1:333102417694884. doi: 10.1177/0333102417694884.
    PubMed     Abstract available


  273. HOLLAND PR, Strother L
    Cilostazol as a chemically induced preclinical model of migraine.
    Cephalalgia. 2017 Jan 1:333102417693832. doi: 10.1177/0333102417693832.
    PubMed    


  274. IYIGUNDOGDU I, Derle E, Asena L, Kural F, et al
    Relationship between white matter hyperintensities and retinal nerve fiber layer, choroid, and ganglion cell layer thickness in migraine patients.
    Cephalalgia. 2017 Jan 1:333102417694882. doi: 10.1177/0333102417694882.
    PubMed     Abstract available


  275. AMBROSINI A, Kisialiou A, Schoenen J
    Reply to the letter by Omland et al.: "Visual and auditory cortical evoked potentials in interictal episodic migraine: The predictive value of a proposed diagnostic test should always be corrected for prevalence".
    Cephalalgia. 2017 Jan 1:333102417695796. doi: 10.1177/0333102417695796.
    PubMed    


  276. CHEN SP, Fuh JL, Chung MY, Lin YC, et al
    Genome-wide association study identifies novel susceptibility loci for migraine in Han Chinese resided in Taiwan.
    Cephalalgia. 2017 Jan 1:333102417695105. doi: 10.1177/0333102417695105.
    PubMed     Abstract available


  277. CHRISTENSEN SL, Petersen S, Sorensen DB, Olesen J, et al
    Cilostazol induces C-fos expression in the trigeminal nucleus caudalis and behavioural changes suggestive of headache with the migraine-like feature photophobia in female rats.
    Cephalalgia. 2017 Jan 1:333102417693833. doi: 10.1177/0333102417693833.
    PubMed     Abstract available


  278. KRAYA T, Mages S, Zierz S
    "Thoracic migraine" as a new manifestation of migraine: Case report.
    Cephalalgia. 2017 Jan 1:333102417733960. doi: 10.1177/0333102417733960.
    PubMed     Abstract available


  279. VAN OOSTERHOUT W, van Someren E, Schoonman GG, Louter MA, et al
    Chronotypes and circadian timing in migraine.
    Cephalalgia. 2017 Jan 1:333102417698953. doi: 10.1177/0333102417698953.
    PubMed     Abstract available


  280. BEN AISSA M, Tipton AF, Bertels Z, Gandhi R, et al
    Soluble guanylyl cyclase is a critical regulator of migraine-associated pain.
    Cephalalgia. 2017 Jan 1:333102417737778. doi: 10.1177/0333102417737778.
    PubMed     Abstract available


  281. SPIERINGS EL, Brandes JL, Kudrow DB, Weintraub J, et al
    Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine.
    Cephalalgia. 2017 Jan 1:333102417737765. doi: 10.1177/0333102417737765.
    PubMed     Abstract available


  282. EDVINSSON L, Warfvinge K
    Recognizing the role of CGRP and CGRP receptors in migraine and its treatment.
    Cephalalgia. 2017 Jan 1:333102417736900. doi: 10.1177/0333102417736900.
    PubMed     Abstract available


  283. LEBEDEVA ER, Gurary NM, Gilev DV, Christensen AF, et al
    Explicit diagnostic criteria for transient ischemic attacks to differentiate it from migraine with aura.
    Cephalalgia. 2017 Jan 1:333102417736901. doi: 10.1177/0333102417736901.
    PubMed     Abstract available


  284. UNEKAWA M, Ikeda K, Tomita Y, Kawakami K, et al
    Enhanced susceptibility to cortical spreading depression in two types of Na+,K+-ATPase alpha2 subunit-deficient mice as a model of familial hemiplegic migraine 2.
    Cephalalgia. 2017 Jan 1:333102417738249. doi: 10.1177/0333102417738249.
    PubMed     Abstract available


  285. JERIC M, Surjan N, Jelicic Kadic A, Riva N, et al
    Treatment of acute migraine attacks in children with analgesics on the World Health Organization Essential Medicines List: A systematic review and GRADE evidence synthesis.
    Cephalalgia. 2017 Jan 1:333102417736902. doi: 10.1177/0333102417736902.
    PubMed     Abstract available


  286. DOMINGUEZ C, Vieites-Prado A, Perez-Mato M, Sobrino T, et al
    Role of adipocytokines in the pathophysiology of migraine. A cross-sectional study.
    Cephalalgia. 2017 Jan 1:333102417731351. doi: 10.1177/0333102417731351.
    PubMed    


  287. PELLEGRINO BAENA C, Goulart AC, Santos IS, Suemoto CK, et al
    Migraine and cognitive function: Baseline findings from the Brazilian Longitudinal Study of Adult Health: ELSA-Brasil.
    Cephalalgia. 2017 Jan 1:333102417737784. doi: 10.1177/0333102417737784.
    PubMed     Abstract available


  288. LABASTIDA-RAMIREZ A, Rubio-Beltran E, Villalon CM, MaassenVanDenBrink A, et al
    Gender aspects of CGRP in migraine.
    Cephalalgia. 2017 Jan 1:333102417739584. doi: 10.1177/0333102417739584.
    PubMed     Abstract available


  289. DEMARQUAY G, Ducros A, Montavont A, Mauguiere F, et al
    Migraine with brainstem aura: Why not a cortical origin?
    Cephalalgia. 2017 Jan 1:333102417738251. doi: 10.1177/0333102417738251.
    PubMed     Abstract available


  290. SUZUKI K, Okuma Y, Uchiyama T, Miyamoto M, et al
    The prevalence, course and clinical correlates of migraine in Parkinson's disease: A multicentre case-controlled study.
    Cephalalgia. 2017 Jan 1:333102417739302. doi: 10.1177/0333102417739302.
    PubMed     Abstract available


  291. KHAN S, Olesen A, Ashina M
    CGRP, a target for preventive therapy in migraine and cluster headache: Systematic review of clinical data.
    Cephalalgia. 2017 Jan 1:333102417741297. doi: 10.1177/0333102417741297.
    PubMed     Abstract available


  292. MCKENDRICK AM, Chan YM, Vingrys AJ, Turpin A, et al
    Daily vision testing can expose the prodromal phase of migraine.
    Cephalalgia. 2017 Jan 1:333102417741130. doi: 10.1177/0333102417741130.
    PubMed     Abstract available


  293. OKRAGLY AJ, Morin SM, DeRosa D, Martin AP, et al
    Human mast cells release the migraine-inducing factor pituitary adenylate cyclase-activating polypeptide (PACAP).
    Cephalalgia. 2017 Jan 1:333102417740563. doi: 10.1177/0333102417740563.
    PubMed     Abstract available


  294. SCHUBERT V, Auffenberg E, Biskup S, Jurkat-Rott K, et al
    Two novel families with hemiplegic migraine caused by recurrent SCN1A mutation p.F1499L.
    Cephalalgia. 2017 Jan 1:333102417742365. doi: 10.1177/0333102417742365.
    PubMed     Abstract available


  295. CHENG CY, Chen SP, Liao YC, Fuh JL, et al
    Elevated circulating endothelial-specific microRNAs in migraine patients: A pilot study.
    Cephalalgia. 2017 Jan 1:333102417742375. doi: 10.1177/0333102417742375.
    PubMed     Abstract available


  296. NAM JH, Lee HS, Kim J, Kim J, et al
    Salivary glutamate is elevated in individuals with chronic migraine.
    Cephalalgia. 2017 Jan 1:333102417742366. doi: 10.1177/0333102417742366.
    PubMed     Abstract available


  297. AGUILA MR, Rebbeck T, Pope A, Ng K, et al
    Six-month clinical course and factors associated with non-improvement in migraine and non-migraine headaches.
    Cephalalgia. 2017 Jan 1:333102417744360. doi: 10.1177/0333102417744360.
    PubMed     Abstract available


  298. BALESTRI M, Papetti L, Maiorani D, Capuano A, et al
    Features of aura in paediatric migraine diagnosed using the ICHD 3 beta criteria.
    Cephalalgia. 2017 Jan 1:333102417748571. doi: 10.1177/0333102417748571.
    PubMed     Abstract available


  299. FARRIS SG, Thomas JG, Abrantes AM, Lipton RB, et al
    Pain worsening with physical activity during migraine attacks in women with overweight/obesity: A prospective evaluation of frequency, consistency, and correlates.
    Cephalalgia. 2017 Jan 1:333102417747231. doi: 10.1177/0333102417747231.
    PubMed     Abstract available


  300. FARAJDOKHT F, Mohaddes G, Shanehbandi D, Karimi P, et al
    Ghrelin attenuated hyperalgesia induced by chronic nitroglycerin: CGRP and TRPV1 as targets for migraine management.
    Cephalalgia. 2017 Jan 1:333102417748563. doi: 10.1177/0333102417748563.
    PubMed     Abstract available


  301. ANDROULAKIS XM, Rorden C, Peterlin BL, Krebs K, et al
    Modulation of salience network intranetwork resting state functional connectivity in women with chronic migraine.
    Cephalalgia. 2017 Jan 1:333102417748570. doi: 10.1177/0333102417748570.
    PubMed     Abstract available


  302. SIVA ZO, Uluduz D, Keskin FE, Erenler F, et al
    Determinants of glucose metabolism and the role of NPY in the progression of insulin resistance in chronic migraine.
    Cephalalgia. 2017 Jan 1:333102417748928. doi: 10.1177/0333102417748928.
    PubMed     Abstract available


  303. ANTONAZZO IC, Riise T, Cortese M, Berge LI, et al
    Diabetes is associated with decreased migraine risk: A nationwide cohort study.
    Cephalalgia. 2017 Jan 1:333102417748573. doi: 10.1177/0333102417748573.
    PubMed     Abstract available


    December 2016
  304. ROMOLI M, Costa C, Siliquini S, Corbelli I, et al
    Antiepileptic drugs in migraine and epilepsy: Who is at increased risk of adverse events?
    Cephalalgia. 2016 Dec 12. pii: 0333102416683925.
    PubMed     Abstract available


  305. VIANA M, Sances G, Terrazzino S, Sprenger T, et al
    When cervical pain is actually migraine: An observational study in 207 patients.
    Cephalalgia. 2016 Dec 7. pii: 0333102416683917.
    PubMed     Abstract available


    November 2016
  306. ABUSHIK PA, Bart G, Korhonen P, Leinonen H, et al
    Pro-nociceptive migraine mediator CGRP provides neuroprotection of sensory, cortical and cerebellar neurons via multi-kinase signaling.
    Cephalalgia. 2016 Nov 24. pii: 0333102416681588.
    PubMed     Abstract available


  307. TRIPATHI R, Tselis A, Bernitsas E
    Bilateral cisternal abducens nerve involvement with ophthalmoplegic migraine.
    Cephalalgia. 2016 Nov 23. pii: 0333102416681569.
    PubMed    


  308. AMBROSINI A, Kisialiou A, Schoenen J
    Visual and auditory cortical evoked potentials in interictal episodic migraine: An audit on 624 patients from three centres. Response to the letter by Omland et al.
    Cephalalgia. 2016 Nov 21. pii: 0333102416680616.
    PubMed    


  309. OMLAND PM, Uglem M, Stovner LJ, Sand T, et al
    Re: Visual and auditory cortical evoked potentials in interictal episodic migraine: An audit on 624 patients from three centres.
    Cephalalgia. 2016 Nov 21. pii: 0333102416680613.
    PubMed    


  310. RICE FL, Xie JY, Albrecht PJ, Acker E, et al
    Anatomy and immunochemical characterization of the non-arterial peptidergic diffuse dural innervation of the rat and Rhesus monkey: Implications for functional regulation and treatment in migraine.
    Cephalalgia. 2016 Nov 16. pii: 0333102416677051.
    PubMed     Abstract available


  311. UGLEM M, Omland PM, Nilsen KB, Tronvik E, et al
    Does pain sensitivity change by migraine phase? A blinded longitudinal study.
    Cephalalgia. 2016 Nov 15. pii: 0333102416679955.
    PubMed     Abstract available


  312. LIU HY, Chou KH, Lee PL, Fuh JL, et al
    Hippocampus and amygdala volume in relation to migraine frequency and prognosis.
    Cephalalgia. 2016 Nov 14. pii: 0333102416678624.
    PubMed     Abstract available


  313. GRECO R, Demartini C, Zanaboni AM, Redavide E, et al
    Effects of kynurenic acid analogue 1 (KYNA-A1) in nitroglycerin-induced hyperalgesia: Targets and anti-migraine mechanisms.
    Cephalalgia. 2016 Nov 14. pii: 0333102416678000.
    PubMed     Abstract available


  314. HEPP Z, Dodick DW, Varon SF, Chia J, et al
    Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis.
    Cephalalgia. 2016 Nov 10. pii: 0333102416678382.
    PubMed     Abstract available


  315. HENSEL O
    Comments on "Longitudinal changes in cerebral blood flow velocities in different clinical courses of migraine" by Lee et al.
    Cephalalgia. 2016 Nov 10. pii: 0333102416678001.
    PubMed    


  316. TOYAMA M, Kudo C, Mukai C, Inoue M, et al
    Trigeminal nervous system sensitization by infraorbital nerve injury enhances responses in a migraine model.
    Cephalalgia. 2016 Nov 9. pii: 0333102416678387.
    PubMed     Abstract available


  317. LEBEDEVA ER, Kobzeva NR, Gilev DV, Kislyak NV, et al
    Psychosocial factors associated with migraine and tension-type headache in medical students.
    Cephalalgia. 2016 Nov 8. pii: 0333102416678389.
    PubMed     Abstract available


  318. MALEKI N, Kurth T, Field AE
    Age at menarche and risk of developing migraine or non-migraine headaches by young adulthood: A prospective cohort study.
    Cephalalgia. 2016 Nov 8. pii: 0333102416677999.
    PubMed     Abstract available


  319. ZHANG Y, Chen N, Zhou M, Guo J, et al
    A novel SCN1A mutation identified in a Chinese family with familial hemiplegic migraine: A case report.
    Cephalalgia. 2016 Nov 8. pii: 0333102416677049.
    PubMed     Abstract available


  320. LISICKI M, Ruiz-Romagnoli E, D'Ostilio K, Piedrabuena R, et al
    Familial history of migraine influences habituation of visual evoked potentials.
    Cephalalgia. 2016 Nov 7. pii: 0333102416673207.
    PubMed     Abstract available


  321. JUAN Y, Shu O, Jinhe L, Na Y, et al
    Migraine prevention with percutaneous mastoid electrical stimulator: A randomized double-blind controlled trial.
    Cephalalgia. 2016 Nov 7. pii: 0333102416678623.
    PubMed     Abstract available


  322. VURALLI D, Boran HE, Cengiz B, Coskun O, et al
    Somatosensory temporal discrimation remains intact in tension-type headache whereas it is disrupted in migraine attacks.
    Cephalalgia. 2016 Nov 4. pii: 0333102416677050.
    PubMed     Abstract available


    October 2016
  323. KALITA J, Bhoi SK, Misra UK
    Effect of high rate rTMS on somatosensory evoked potential in migraine.
    Cephalalgia. 2016 Oct 25. pii: 0333102416675619.
    PubMed     Abstract available


  324. STREEL S, Donneau AF, Dardenne N, Hoge A, et al
    Screening for the metabolic syndrome in subjects with migraine.
    Cephalalgia. 2016 Oct 4. pii: 0333102416672494.
    PubMed     Abstract available


    September 2016
  325. IBRAHIMI K, Vermeersch S, Frederiks P, Geldhof V, et al
    The influence of migraine and female hormones on capsaicin-induced dermal blood flow.
    Cephalalgia. 2016 Sep 28. pii: 0333102416668659.
    PubMed     Abstract available


  326. SAMANCI B, Coban O, Baykan B
    Late onset aura may herald cerebral amyloid angiopathy: A case report.
    Cephalalgia. 2016;36:998-1001.
    PubMed     Abstract available


  327. KAUFMANN D, Bates EA, Yagen B, Bialer M, et al
    sec-Butylpropylacetamide (SPD) has antimigraine properties.
    Cephalalgia. 2016;36:924-35.
    PubMed     Abstract available


    August 2016
  328. ZHANG X, Strassman AM, Novack V, Brin MF, et al
    Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors' responses to stimulation of TRPV1 and TRPA1 channels: Are we getting closer to solving this puzzle?
    Cephalalgia. 2016;36:875-86.
    PubMed     Abstract available


  329. NAGY-GROCZ G, Tar L, Bohar Z, Fejes-Szabo A, et al
    The modulatory effect of anandamide on nitroglycerin-induced sensitization in the trigeminal system of the rat.
    Cephalalgia. 2016;36:849-61.
    PubMed     Abstract available


  330. RAUSCHEL V, Ruscheweyh R, Krafczyk S, Straube A, et al
    Test-retest reliability of visual-evoked potential habituation.
    Cephalalgia. 2016;36:831-9.
    PubMed     Abstract available


    May 2016
  331. RAUCCI U, Vanacore N, Paolino MC, Silenzi R, et al
    Vertigo/dizziness in pediatric emergency department: Five years' experience.
    Cephalalgia. 2016;36:593-8.
    PubMed     Abstract available


    February 2016
  332. BURGOS-VEGA CC, Ahn DD, Bischoff C, Wang W, et al
    Meningeal transient receptor potential channel M8 activation causes cutaneous facial and hindpaw allodynia in a preclinical rodent model of headache.
    Cephalalgia. 2016;36:185-93.
    PubMed     Abstract available


    January 2016
  333. MAY A
    Letter from the Editor-in-Chief.
    Cephalalgia. 2016;36:3-4.
    PubMed    


  334. ABU BAKAR N, Tanprawate S, Lambru G, Torkamani M, et al
    Quality of life in primary headache disorders: A review.
    Cephalalgia. 2016;36:67-91.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Migraine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: